Article
Pharmacogenomics in clinical drug development and potential for alopecia areata.
The journal of investigative dermatology. Symposium proceedings - 1 Dec 2013
Warner Amelia W
Abstract excerpt
Alopecia areata, alopecia totalis, and alopecia universalis likely represent a constellation of related diseases with similar, yet distinct heritability markers. There is currently no known curative therapy that works universally for all patients. Pharmacogenomic research enables the pharmaceutical industry to understand variability of patient responses to drugs during clinical drug development and during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
